Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MERUS LABS INTERNATIONAL INC
T.MSL
Healthcare
Drug Manufacturers - Specialty & Generic
"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
GoldBug024
X
View Profile
View Bullboard History
Comment by
GoldBug024
on Jun 06, 2017 4:07pm
RE:Management Circular
yes "due dilleigence"... More like you get us a 30 cent discount and we will make sure you big guys get taken care of one way or another. Market's have me disillusioned.
(178)
•••
Contrarian333
X
View Profile
View Bullboard History
Post by
Contrarian333
on Jun 06, 2017 8:59am
Management Circular
That was some due diligence that knocked the original indicated bid price from $1.95 to $1.65 - and had the Board endorse it.
(0)
•••
GoldBug024
X
View Profile
View Bullboard History
Comment by
GoldBug024
on May 31, 2017 10:20am
RE:RE:RE:Next steps..
they wouldn't have even considered tabling this offer to shareholders to vote on if b Goodman wasn't already on board. Plus the guys accumulating shares above 1.60 aren't going to vote no.
...more
(1)
•••
peter75
X
View Profile
View Bullboard History
Comment by
peter75
on May 20, 2017 10:41am
RE:Out at 1.61
Vitaly look at edge point global equity fund mawyer canadien equity manulife black rock plan 8322 if you buy these three over time you will make great returns
(2179)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 17, 2017 1:21pm
Mtg July 10 to vote on buyout
Per sedar
(95)
•••
hipfner
X
View Profile
View Bullboard History
Comment by
hipfner
on May 13, 2017 11:10am
RE:Out at 1.61
When you say "funds" I hope that you mean Exchange Traded Funds rather than mutual funds. ETFs are tradable all day whereas the price for a mutual fund is set daily after the market closes.
...more
(0)
•••
Vitaly1977
X
View Profile
View Bullboard History
Post by
Vitaly1977
on May 13, 2017 9:05am
Out at 1.61
Thank you guys, I am probably a junior trader so it was my first big loss, but I decided to get out and do not play with the chance as you suggested.. Will probably concentrate more into funds than
...more
(1)
•••
peter75
X
View Profile
View Bullboard History
Comment by
peter75
on May 12, 2017 8:07am
RE:RE:Next steps..
Vitaly if you had 500 shares the four cent difference is 20 bucks on 5000 shares its 200 bucks Take your loss and move on while you can There is a chance this deal never closes and your shares will
...more
(5)
•••
jammo71
X
View Profile
View Bullboard History
Comment by
jammo71
on May 12, 2017 6:15am
RE:Next steps..
While anything's possible, to hang on hoping that there will be a better offer is not a very good investment strategy. The release specifically states that the offer is "financially fair"
...more
(1)
•••
ydakhel
X
View Profile
View Bullboard History
Comment by
ydakhel
on May 12, 2017 4:20am
RE:RE:RE:Not so Great
I have to disagree here. I didn't see this stock going to $2 anytime soon. I was waiting for a "pop" in the share price to sell and move on. I am glad I am getting $1.65. I am still
...more
(0)
•••
rickety1
X
View Profile
View Bullboard History
Comment by
rickety1
on May 11, 2017 11:42pm
RE:RE:Next steps..
There is also a chance that the deal will fall through!!
(2179)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on May 11, 2017 10:16pm
RE:Next steps..
If you sell now you may get $1.61 in mkt...if you wait till buyout closes you get $1.65, or 2.5% more over say 4 months to close deal or 7.5% annualized return.....if you have better use for the money
...more
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on May 11, 2017 3:07pm
RE:RE:RE:Great call by Deadlock
it is definitive agreement at 1.65, you can wait it out until the transaction has closed and your paper will be converted to 1.65 per piece. if you sell now, let's say 1.61, there will be people
...more
(1)
•••
peter75
X
View Profile
View Bullboard History
Comment by
peter75
on May 11, 2017 3:04pm
RE:RE:RE:Not so Great
Kensin you are so true have a look at Crh medical crh I would take a small position and when it goes up a bit, add some more I own , it's my largest position
(0)
•••
Vitaly1977
X
View Profile
View Bullboard History
Comment by
Vitaly1977
on May 11, 2017 2:42pm
RE:RE:Great call by Deadlock
So in my case the best way is to sell ASAP before it dips again (if...)?:) No room to run up, right?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment